thetrading.tools
StocksCalendar daily · performance after each close

IPO & New Listings Tracker: Who's Coming to Market, and How New Stocks Trade

The US deal calendar — expected, priced and withdrawn — next to the question calendars never answer: how do recent listings actually trade once they're public? Every return is measured from the first close a buyer could get, never the offer price, and the performance layer is built survivorship-honest: a frozen equal-weight index cross-checked against the investable Renaissance IPO ETF, because our own database only remembers the listings that lived. Cross-check live action on Unusual Volume and the Momentum Scanner.

Latest reading

As of October 9, 2026, recent listings read lagging versus the market: the investable Renaissance IPO ETF's relative strength against SPY sits at the 21th percentile of the post-2013 record, down 7.8% over the past quarter (our own 334-stock survivor cohort is kept as the beneath-the-surface exhibit). On the calendar, 56 deals have priced since August 14, 2026 and 116 sit in the pipeline, with 20 withdrawn.

Sources, methodology & freshnessFinnhub IPO calendar (archived daily) + our own daily price database for listings detection and returns; Renaissance IPO ETF as the investable cross-check · Calendar daily; performance after each market closeData as of 2026-10-09 · Open ↓
Source
Finnhub IPO calendar (archived daily) + our own daily price database for listings detection and returns; Renaissance IPO ETF as the investable cross-check
Methodology
Listing date = first daily bar; equal-weight trailing-24-month index, monthly rebalanced, frozen append-only and validated against the IPO ETF; returns from first close, never offer price; cohorts labeled survivors-only
Updates
Calendar daily; performance after each market closeData as of 2026-10-09
Maintained & reviewed by Yuriy Matso — methodology shown on the page.
IPO Trackeras of 2026-10-09
Lagging
recent listings vs the market

Relative strength of the investable Renaissance IPO ETF vs SPY, at the 21th percentile of the post-2013 record.

RS 63-session
-7.8%
Priced (archive)
56
Pipeline
116
01

Recently priced — deals that made it out

Every deal that priced since the archive opened on August 14, 2026, newest first. The price column is the final offer price; deal size is shares × price where both disclosed. Names begin appearing in the performance tables a few sessions after they start trading.

PAXGUPine Tree Acquisition Copriced
2026-10-06$10.00$100M
PORTUSouthport Acquisition Copriced
2026-10-01$10.00$200M
CHWMChilwa Minerals Ltdpriced
2026-10-01$5.60$4M
ACCVAccelevation Holdings Copriced
2026-09-30$18.00$540M
RZAIROZE AI INC.priced
2026-09-29——
BRRKUBluerock Acquisition Corpriced
2026-09-25$10.00$150M
ADRXADARx Pharmaceuticals, Ipriced
2026-09-25$17.00$446M
LOVIULive Oak Acquisition Corpriced
2026-09-23$10.00$200M
OIGOrion180 Insurance Grouppriced
2026-09-18$12.00$240M
LEDRULeader's Advantage Acquipriced
2026-09-18$10.00$150M
ETRAElectra Therapeutics, Inpriced
2026-09-18$15.00$350M
HYACUHaymaker Acquisition Corpriced
2026-09-17$10.00$250M
LEDRULeader's Advantage Acquipriced
2026-09-04$10.00$150M
TRBGTurbogen Ltd.priced
2026-09-03——
TLACUThree Lions Acquisition priced
2026-09-01$10.00$100M
IPHXUInflection Point Acquisipriced
2026-08-28$10.00$250M
RNAQURainier Acquisition Corppriced
2026-08-27$10.00$75M
SCATUSouthern Cross Acquisitipriced
2026-08-26$10.00$75M
JTTTJATT III Acquisition Corpriced
2026-08-26$10.00$60M
ADBTAdvasa Holdings, Inc.priced
2026-08-25——

Showing the 20 most recent of 56 priced deals in the archive.

02

The pipeline — expected and filed

Deals that have filed or set an expected date but not yet priced. Price ranges are the bankers' proposed band and routinely move — a cut range or a slipped date is the tell that the book is soft. 20 archived deals have been withdrawn — pulled deals lead a cooling calendar by weeks.

TRXBTRex Bio, Inc.expected
2026-10-09$14.00–$16.00$153M
RTSNRetension Pharmaceuticalexpected
2026-10-09$11.00–$13.00$49M
FFLYFireFly Robotics, Inc.filed
2026-10-07——
CNTLCentinel Spine Holdco, Ifiled
2026-10-07—$100M
AFNXUAfterNext Acquisition I expected
2026-10-07$10.00$115M
TCAATANG CAPITAL ACQUISITIONfiled
2026-10-06—$75M
NIAAUNew Iceland Arctic Acquifiled
2026-10-05—$115M
LYCALycia Therapeutics, Inc.filed
2026-10-05—$100M
DODCDayOne Data Centers Ltdfiled
2026-10-05—$100M
LPCILPC LTDfiled
2026-10-02—$26M
GBCGEORGIA BANKING CO INCfiled
2026-10-02——
ANACUArca Nova Acquisition Cofiled
2026-10-02—$115M
PGAPOP GLOBAL ACQUISITION Lfiled
2026-10-01—$115M
YHTEPrimagrove Ltdfiled
2026-09-30—$43M
PTTSIYATA PTTexpected
2026-09-30——
OURAOura Inc.expected
2026-09-30$40.00–$44.00$2.53B
BHAIUBHAV Acquisition Corp IIfiled
2026-09-30—$173M
AFNXUAfterNext Acquisition I expected
2026-09-30$10.00$115M
MNBSUMNBS Acquisition Corp.filed
2026-09-29—$86M
SRAVSource Agriventures Inc.filed
2026-09-28—$15M

Showing the 20 most recent of 116 pipeline entries.

03

Recent listings — how they've traded since

Every name in our universe that listed within the trailing 24 months, with returns from its first recorded close, the first price generally available. Returns never start from the allocated offer price. IPO-verified means the deal appears priced in our calendar archive; unverified names include SPACs, direct listings, spinoffs and uplistings. Listings enter this table after identity verification against our common-stock snapshot, so the newest debuts can lag their first trading day by a few weeks.

RNA-43.1%
2026-02-273M -11.9%$11.0B
AKTS-19.0%
2026-01-093M -22.6%$1.2B
BUDA-6.3%
2026-01-083M +28.0%$111M
ALUB+2.0%
2026-01-063M —$362M
BVC+0.8%
2025-12-243M -18.9%$1.6B
RENX-67.1%
2025-12-193M -62.5%$1M
FJET-81.2%
2025-12-183M -20.8%$401M
ANDG+141.8%
2025-12-173M +18.7%$2.6B
MDLN-11.6%
2025-12-173M +4.2%$38.2B
VSNT-32.9%
2025-12-153M -21.3%$4.5B
WLTH-23.7%
2025-12-123M -44.6%$1.3B
LMRI-43.1%
2025-12-113M -29.0%$1.4B
CDNL-10.1%
2025-12-103M +25.3%$1.0B
DCX-99.8%
2025-12-103M -82.3%$2M
XXI-44.9%
2025-12-093M -41.2%$2.8B
MICC+15.8%
2025-12-083M +3.9%$10.0B
HYNE+19.9%
2025-12-043M +4.0%$119M
RGNT-78.7%
2025-12-043M —$38M
SMJF-66.1%
2025-12-043M -34.4%$144M
DMII+3.1%
2025-12-033M +0.6%$654M
EVOX+2.3%
2025-12-033M +1.1%$319M
PARK+97.6%
2025-12-033M +91.6%$79M
PURR+184.9%
2025-12-033M +11.0%$432M
AIIA+3.4%
2025-11-243M —$193M
RNGT+1.9%
2025-11-243M —$312M
KRSP-1.2%
2025-11-213M -3.6%$481M
BCSS+1.5%
2025-11-203M +1.2%$594M
VACI-22.3%
2025-11-203M —$312M
ALIS+1.5%
2025-11-193M —$85M
DNMX+1.4%
2025-11-193M +0.0%$266M
GLOO-52.7%
2025-11-193M -30.2%$512M
DYOR+2.0%
2025-11-183M —$229M
APXT+2.4%
2025-11-173M +0.6%$457M
FCRS-0.3%
2025-11-173M -1.7%$367M
FWDI-13.6%
2025-11-173M -46.8%$668M
WSHP-84.0%
2025-11-143M +25.5%$704M
POAS-96.4%
2025-11-133M -76.9%$45M
CHEC+2.9%
2025-11-113M +0.6%$174M
LATA+1.0%
2025-11-103M -0.9%$230M
AERO-23.5%
2025-11-063M -6.5%$3.0B
BLLN-10.0%
2025-11-063M -15.2%$4.1B
EVMN-69.1%
2025-11-063M -16.0%$595M
LKSP+3.3%
2025-11-063M —$195M
SUNC+50.5%
2025-11-063M +8.8%$2.7B
ELWT-16.7%
2025-11-053M -31.5%$41M
XZO-23.9%
2025-11-053M -16.2%$1.9B
BETA-41.7%
2025-11-043M -56.1%$5.8B
CEPV-0.7%
2025-11-043M -1.0%$325M
OTGA+2.3%
2025-11-033M —$297M
Q+30.5%
2025-11-033M -1.5%$20.7B

Showing 50 of 324 listings in the trailing 24 months.

04

The recent-listings index — and the survivorship story

An equal-weight index of every common stock listed within the trailing 24 months (334 names today), monthly rebalanced, since October 16, 2013. The history is frozen append-only: computed once, then extended one day at a time — so when a listing later dies and leaves our database, the index history it lived through never restates. The validation below is why this in-house index is the exhibit, not the gauge: the page's regimes and forward study run on the investable Renaissance IPO ETF instead.

Range:
101.7680.61259.52014201620182020202220242026SPY (top pane, log)7791206
Equal-weight index of US common stocks listed within the trailing 24 months, rebalanced monthly, 2013-10-16 = 100, frozen through 2026-10-09. SPY in the top pane (log scale).

The survivorship check — our index vs the investable Renaissance IPO ETF

Our database prunes delisted stocks with their full history, so a naively recomputed index contains only winners. The check caught exactly that: since October 16, 2013 our survivor index returned +1106.1% cumulative versus +162.3% for the Renaissance IPO ETF (IPO) — 4.6× the investable fund's growth, with a daily-return correlation of 0.65. In-house equal-weight survivor index grew 4.6x the investable ETF over the same window (survivorship inflation, the RSP lesson again). The ETF is the primary series on this page; the in-house index is the beneath-the-surface exhibit.

The same check as one line: our index divided by the ETF, both rebased to 100 at the start. Flat means tracking; a persistently rising line is our survivor universe inflating past the fund that actually held the failures.

Range:
100304.8509.52014201620182020202220242026452
Our frozen recent-listings index divided by the Renaissance IPO ETF, both rebased to 100 at the first common session. Divergence above 100 measures survivorship inflation plus weighting differences (ours equal-weight, the ETF cap-weighted).
05

Regimes — and what happened next

Edge test: Survivorship artifact

The Renaissance IPO ETF's relative strength versus SPY — the investable series, not our survivor index — read as a rolling percentile of its own history and bucketed into Cold / Lagging / Neutral / Warm / Hot. Today: Lagging, at the 21th percentile. The apparent pattern did not survive the cross-check against the investable ETF — it is a property of our survivor universe, not of the market. The tables remain published for transparency, but nothing here should be read as a signal.

The in-house survivor index grew 4.6x the investable IPO ETF over the same window (corr 0.65) — consistent with survivorship inflation, not IPO outperformance (the Ritter record has IPO cohorts underperforming). The ETF is this page's honest primary series; regimes and the forward study are computed on the ETF, and the in-house index is shown only as the survivorship exhibit.

RegimeDaysFwd 63s SPY medianWin rate
Cold320-0.1%49%
Lagging ← today958+3.7%71%
Neutral639+3.5%77%
Warm958+4.0%83%
Hot319+5.8%90%
Forward SPY returns from each regime day; daily observations overlap, so complete-window counts overstate independent samples. The most recent days have no completed forward window and are excluded from the counts.
06

Cohorts by listing year — the boom-bust record

Every listing year's class, graded 12 months after each name's first close. These rows are survivors-only: delisted names are pruned from our database with their history, so each cohort is missing exactly the names that did worst. Read the medians as an upper bound — the academic record (Ritter) finds full IPO cohorts underperform the market for three to five years.

ListedSurvivorsMedian 12Mvs SPY
201290+21.6%+6.4%
2013134+9.8%-9.7%
2014157-0.4%-5.7%
2015147-7.0%-9.6%
2016103+18.4%+1.7%
2017134+3.8%-8.0%
2018171-6.4%-12.8%
2019155-11.5%-19.7%
2020251+1.0%-30.3%
2021416-41.6%-40.5%
2022126-15.4%-18.9%
2023119-22.9%-54.8%
2024174-15.4%-33.3%
2025275+0.1%-24.0%
20264——
Returns from each name's first recorded close; names without 12 months of history yet are excluded from the medians. Survivor counts, not true listing counts — the real cohorts were larger.

How IPO & New Listings Tracker Works

  1. 1
    Archive the calendar daily
    The upcoming and recently priced deal list is pulled from the Finnhub IPO calendar every day and archived incrementally — expected deals, priced deals with their offer price and raise size, and withdrawals. Once a deal appears it stays in the archive, so the pipeline history accumulates.
  2. 2
    Detect listings from our own price data
    A stock's listing date is its first daily bar in our 5,500-symbol price database. Names that appear in the priced calendar are tagged as verified IPOs; the rest are labeled new listings, which also catches SPACs, direct listings, spinoffs and uplistings. The universe excludes ETFs, preferreds and index tickers via our common-stock filter.
  3. 3
    Build the recent-listings index — then freeze it
    An equal-weight index of every common stock listed within the trailing 24 months, monthly rebalanced, computed since the Renaissance IPO ETF's 2013 inception. The history is frozen append-only: computed once, validated against the investable ETF, then extended one day at a time — so later delistings can never quietly restate the past.
  4. 4
    Grade the base rates before shipping them
    Forward returns are graded per listing-year cohort and per relative-strength regime, and the whole study is edge-tested against the academic prior that IPO cohorts underperform for years. If our surviving names show outperformance the academic record contradicts, the page says survivorship artifact — not edge.

Who Uses IPO & New Listings Tracker

Deal watchers
One page for what is coming to market: expected deals with their price ranges, what actually priced and at what raise size, and what got pulled — with the withdrawal count as its own risk-appetite tell.
New-issue traders
The recent-listings table shows how every name that listed in the past two years has traded since its first close — 1, 3, 6 and 12 months out — so a hot IPO can be judged against how its whole vintage is behaving, not in isolation.
Risk-appetite readers
Recent listings are the market's longest-duration, lowest-track-record cohort — when they lead the tape, speculative appetite is running; when they lag badly, it has left. The regime state tracks that in one line.
Cycle historians
The cohort table is the boom-bust record by listing year: the 2021 listing spike and the cohort's subsequent drawdown sit next to the thin 2022–23 vintages — with the survivors-only caveat printed on the table itself.

Pro Tips

01
Returns start at the first close
Every return here is measured from a name's first recorded close — the price a retail buyer could actually get — not the offer price handed to allocated institutions. Headline "IPO pop" statistics use the offer price and will always look better than what was buyable.
02
Watch the ETF gap as well as our index
Our equal-weight index only contains names that still exist — failed listings are pruned from the database with their history. The investable Renaissance IPO ETF held the failures all the way down. When the two diverge, believe the ETF.
03
The withdrawal column leads the pipeline
Deals get pulled when bankers can't build the book — a run of withdrawals and range cuts usually precedes a thin pricing calendar by weeks, and it turns before the priced count does.
04
A SPAC unit is not an IPO
The listings-broad detection catches SPAC units, direct listings and uplistings alongside true IPOs. The IPO-verified tag separates deals confirmed in the priced calendar; treat untagged names accordingly.

Common Issues & Solutions

A recent IPO is missing from the tables▾
New symbols enter our price database via a daily ingestion step after they price and begin trading; a name can lag its debut by a few sessions. If it is in the calendar but not the performance tables, it has not been ingested yet.
The cohort returns look better than famous IPO studies▾
That is survivorship, and the page says so: delisted names are pruned from our database with their full history, so live-computed cohorts contain only survivors. The frozen index and the ETF comparison exist precisely to bound that bias.
A listing date looks wrong▾
Listing dates are first-bar dates in our price data. Ticker changes, uplistings from OTC, and relistings can print a first bar that differs from the company's actual public debut; the IPO-verified tag marks names whose pricing we can confirm from the calendar archive.
The index and the ETF disagree on a given week▾
They should track directionally, not exactly — ours is equal-weight across every qualifying listing, while the ETF is cap-weighted across a narrower basket. A persistent level gap is the survivorship signal; week-to-week wiggle is weighting.

Frequently Asked Questions

What is the difference between an IPO and a new listing?▾
An IPO is a company selling new shares to the public through an underwritten offering with an offer price. A new listing is anything that starts trading — IPOs, but also SPAC units, direct listings, spinoffs and uplistings from OTC markets. This page tracks all new listings and tags the ones verified as priced IPOs in the calendar archive.
How do IPOs perform after they start trading?▾
The academic record (Ritter and successors) finds IPO cohorts underperform the market for three to five years after listing, largely driven by the weakest names. Our cohort tables measure the same thing from each name's first close — with the honest caveat that our database contains only survivors, which flatters the result.
What is survivorship bias and why does this page keep mentioning it?▾
Databases that drop dead companies make history look better than it was — the listings that went to zero vanish from the record. Our price database prunes delisted names, so every live-computed cohort is survivors-only. The frozen index history and the comparison against the investable Renaissance IPO ETF (which held the failures) are the two mechanisms this page uses to keep that bias visible instead of hidden.
What does the recent-listings index measure?▾
An equal-weight basket of every US common stock in our universe that listed within the trailing 24 months, rebalanced monthly and compared against SPY. It answers whether the market's newest, least-proven cohort is leading or lagging. It is a speculative-appetite gauge. It is not a buy list.
Why do returns here start at the first close instead of the offer price?▾
Offer-price allocations go to institutions before trading begins; the first close is the first price generally available. First-day pop statistics measured from the offer price describe a return most investors never had access to, so this page does not use them.
How often does this page update?▾
The calendar refreshes every day from the Finnhub IPO calendar, and the performance layer recomputes after each market close from our own daily price data. The index history itself is frozen and only extends forward — past values never restate.

Explore Other Tools